...we will explore the positive and negative implications of gabapentinoid plus opioid therapy, specific evidence that supports the use of cannabinoids in the management of chronic pain (and does it reduce opioid burden), and other controversial issues.
MONTCLAIR, N.J. (PRWEB) June 18, 2019
At PAINWeek 2019, the extensive agenda will be augmented with 3 workshops highlighting ultrasonography; therapeutic pharmacologic options; and buprenorphine. The half-day workshops will be led by senior PAINWeek faculty and require a supplemental conference registration fee.
Innovations in Pain Medicine Ultrasonography: Image Guidance, Diagnosis, and Emerging Applications
This workshop will cover the latest evidence-based rationale for ultrasound image guidance interventions vs other modalities. Presenter Jennifer M. Hah, MD, MS, commented, “We look forward to discussing the rapid advances in the field of pain medicine ultrasonography for both image guidance and diagnosis. The hands-on stations and close interface with expert faculty will facilitate skills acquisition for real-world application to treat common musculoskeletal conditions.” An introduction to diagnostic ultrasonography will be presented covering common pain conditions, and emerging applications for pain medicine ultrasonography particularly relating to peripheral nerve stimulation, regenerative medicine, cryotherapy, and radiofrequency will be discussed. Dr. Hah will co-present with Einar Ottestad, MD, on Tuesday, September 3, 1:40-4:40.
Hitting the Bull’s Eye in Pain Management: Using All the Arrows in Your Quiver
“Rarely is one medication or pharmacologic class of drugs the answer to a medical conundrum, including pain management,” commented presenter Mary Lynn McPherson, PharmD, MA, BCPS, CPE. “While opioids are indisputably valuable in treating acute pain and some forms of chronic pain, they are just one therapeutic option.” Participants in this fast-paced, case-based session will learn about the appropriate use of different medications in lieu of or in combination with opioid therapy. Dr. McPherson continued, “Along the way we will explore the positive and negative implications of gabapentinoid plus opioid therapy, specific evidence that supports the use of cannabinoids in the management of chronic pain (and does it reduce opioid burden), and other controversial issues.”
Participants will learn how to deal with difficult pain syndromes including wound pain, complicated neuropathic pain, and functional pain syndromes. Copresenting on Wednesday, September 4, from 9:30-12:30, will be Alexandra McPherson, PharmD, MPH.
Rotate the Molecule! Rationalizing Excessive Opioid Prescribing with Buprenorphine
Buprenorphine, a partial mu agonist, was recently made available for the treatment of opioid dependency in the office-based setting. It is enjoying a renewed popularity as an opioid analgesic for the treatment of chronic pain. In this workshop, attendees will explore problematic and sometimes excessively high opioid prescription levels in the context of a treatable clinical condition; case-based examples will be provided. The basics of buprenorphine pharmacology, clinical utility, and the regulatory status of a variety of currently available preparations will be examined through the prism of current as well as past peer reviewed literature. This workshop will be presented by senior faculty member Douglas L. Gourlay, MD, MSc, FRCPC, FASAM, on Wednesday, September 4, from 1:40-4:40.
To maximize the workshop experience, seating will be limited, and early registration is encouraged. Please (go here) to register and learn more.
PAINWeek, the largest US pain conference for frontline clinicians with an interest in pain management, will convene for its 13th annual meeting on September 3-7 at The Cosmopolitan of Las Vegas. The conference presents 120+ hours of continuing medical education courses and master classes, special interest sessions, and satellite events. Approximately 2,000 practitioners are expected to attend.
About Global Education Group:
Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.